Cinobufagin suppresses colorectal cancer angiogenesis by disrupting the endothelial mammalian target of rapamycin/hypoxia‐inducible factor 1α axis-Reference-Cited by-同舟云学术

Cinobufagin suppresses colorectal cancer angiogenesis by disrupting the endothelial mammalian target of rapamycin/hypoxia‐inducible factor 1α axis

Published:2019-03-29 Issue:5 Volume:110 Page:1724-1734
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Li Xiaowu¹²³,Chen Chunhui²,Dai Yu²,Huang Chengzhi¹,Han Qinrui²,Jing Linlin⁴,Ma Ye²,Xu Yihua²,Liu Yawei⁵,Zhao Liang⁵,Wang Junjiang¹,Sun Xuegang²⁶^ORCID,Yao Xueqing¹²

Affiliation:

1. Department of Gastrointestinal SurgeryGuangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences Guangzhou Guangdong China

2. The Key Laboratory of Molecular BiologyState Administration of Traditional Chinese MedicineSchool of Traditional Chinese MedicineSouthern Medical University Guangzhou China

3. Department of General SurgeryThe First Affiliated Hospital & School of Clinical Medicine of Guangdong Pharmaceutical University Guangzhou China

4. Traditional Chinese Medicine Integrated HospitalSouthern Medical University Guangzhou China

5. Nanfang HospitalSouthern Medical University Guangzhou China

6. School of Basic Medical SciencesSouthern Medical University Guangzhou China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link